Cas:1256-86-6 cholesterol sulfate manufacturer & supplier

We serve Chemical Name:cholesterol sulfate CAS:1256-86-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

cholesterol sulfate

Chemical Name:cholesterol sulfate
CAS.NO:1256-86-6
Synonyms:Cholesterol 3-sulfate;cholestenol;Chol-sulf;cholesterol sulphate;Cholest-5-en-3beta-ol sulfate;[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate;CHOLEST-5-EN-3-YL HYDROGEN SULFATE;Cholesteryl sulfate;Cholesterol sulfic acid
Molecular Formula:C27H46O4S
Molecular Weight:466.71700
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.12g/cm3
Index of Refraction:
PSA:71.98000
Exact Mass:466.31200
LogP:8.29660

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Cholesterol 3-sulfate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Cholesterol sulfic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,cholesterol sulphate Use and application,CHOLEST-5-EN-3-YL HYDROGEN SULFATE technical grade,usp/ep/jp grade.


Related News: One way of leveraging the many benefits of biocatalysis is to partner with an API CDMO offering comprehensive expertise and experience in developing and implementing such technology in GMP commercial production. 4-(fluoromethyl)benzaldehyde manufacturers It now operates fourteen plants across four continents, including two in southern California it inherited from its $112 million acquisition of German plastic packaging firm Balda in 2016. exo-2-Chloro-5,5-ethylenedioxy-bicyclo[2.2.1]heptane-syn-7- carboxylic acid suppliers ICER’s researchers used a two-year treatment horizon in their model but noted that it’s unclear how long patients are supposed to remain on these treatments. The model may not fully capture the challenges the disease presents to patients, ICER acknowledged. 4-methyl-2-(4-methylphenyl)pyridine vendor & factory.